ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 131 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.31 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,508,371 | -19.8% | 1,197,472 | +12.6% | 0.02% | -11.8% |
| Q2 2023 | $6,868,143 | +19.5% | 1,063,180 | +39.5% | 0.02% | +6.2% |
| Q1 2023 | $5,748,089 | -40.9% | 762,346 | -20.6% | 0.02% | -48.4% |
| Q4 2022 | $9,732,013 | -18.0% | 960,712 | -20.0% | 0.03% | -22.5% |
| Q3 2022 | $11,873,000 | +53.2% | 1,200,538 | +64.9% | 0.04% | +53.8% |
| Q2 2022 | $7,752,000 | +60.3% | 727,922 | +46.8% | 0.03% | +85.7% |
| Q1 2022 | $4,836,000 | -34.4% | 495,984 | -3.8% | 0.01% | -12.5% |
| Q4 2021 | $7,373,000 | +337.6% | 515,600 | +513.1% | 0.02% | +300.0% |
| Q3 2021 | $1,685,000 | -79.7% | 84,100 | -77.7% | 0.00% | -78.9% |
| Q2 2021 | $8,299,000 | +119.6% | 377,216 | +239.0% | 0.02% | +90.0% |
| Q1 2021 | $3,779,000 | – | 111,285 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |